Rituximab-associated HBV Reactivation in Lymphoma Patients with Resolved Hepatitis B: Kinetics of Anti-HBs Titers with or without Entecavir Prophylaxis

被引：0
|
作者：
Huang, Yi-Hsiang [1 ,2 ]
Lee, I-Cheng [1 ,2 ]
Hsiao, Liang-Tsai [3 ]
Lin, Han-Chieh [1 ]
Lee, Shou-Dong [4 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan
[4] Cheng Hsin Gen Hosp, Taipei, Taiwan
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
932
引用
收藏
页码：652A / 652A
页数：1
相关论文
共 50 条
  • [1] Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
    Huang, Yi-Hsiang
    Hsiao, Liang-Tsai
    Hong, Ying-Chung
    Chiou, Tzeon-Jye
    Yu, Yuan-Bin
    Gau, Jyh-Pyng
    Liu, Chun-Yu
    Yang, Muh-Hwa
    Tzeng, Cheng-Hwai
    Lee, Pui-Ching
    Lin, Han-Chieh
    Lee, Shou-Dong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) : 2765 - +
  • [2] Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers
    Nishida, Tsutomu
    Matsubara, Tokuhiro
    Yakushijin, Takayuki
    Inada, Masami
    HEPATOLOGY INTERNATIONAL, 2019, 13 (04) : 407 - 415
  • [3] Prediction and clinical implications of HBV reactivation in lymphoma patients with resolved HBV infection: focus on anti-HBs and anti-HBc antibody titers
    Tsutomu Nishida
    Tokuhiro Matsubara
    Takayuki Yakushijin
    Masami Inada
    Hepatology International, 2019, 13 : 407 - 415
  • [4] High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma
    Cho, Yuri
    Yu, Su Jong
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Kim, Tae Min
    Heo, Dae Seog
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (06) : 1010 - 1017
  • [5] Characteristics of anti-HBs titers by gender and age in HBV-resolved patients
    Iio, Etsuko
    Watanabe, Tsunamasa
    Ohne, Kumiko
    Matsuura, Kentaro
    Shinkai, Noboru
    Nojiri, Shunsuke
    Joh, Takashi
    Wakimoto, Yukio
    Tanaka, Yasuhito
    HEPATOLOGY, 2012, 56 : 432A - 433A
  • [6] Kinetics of the anti-HBs Titers After Vaccination Against Hepatitis B Virus(HBV) in Patients With Inflammatory Bowel Disease (IBD)
    Chaparro, Maria
    Nogueiras, Amelia Rodriguez
    Villagrasa, Jose R.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S589 - S589
  • [7] Kinetics of the anti-HBs Titers After Vaccination Against Hepatitis B Virus (HBV) in Patients With Inflammatory Bowel Disease (IBD)
    Gisbert, Javier P.
    Villagrasa, Jose R.
    Nogueiras, Amelia Rodriguez
    Chaparro, Maria
    GASTROENTEROLOGY, 2012, 142 (05) : S349 - S349
  • [8] Hepatitis B reactivation with rituximab in an HIV-infected anti-HBs antibody carrier
    Benghalia, K.
    Roussin-Bretagne, S.
    Marque-Juillet, S.
    Colardelle, P.
    Chochon, M.
    Harzic, M.
    Doll, J.
    MEDECINE ET MALADIES INFECTIEUSES, 2011, 41 (08): : 437 - 439
  • [9] RITUXIMAB-ASSOCIATED HEPATITIS B VIRUS (HBV) REACTIVATION IN LYMPHOPROLIFERATIVE DISEASES: CASE REPORTS
    Bougherira, S.
    Meghadcha, M. E. H.
    HAEMATOLOGICA, 2015, 100 : 714 - 715
  • [10] Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: A case report and literature review
    Ferreira, Rosa
    Carvalheiro, Joana
    Torres, Joana
    Fernandes, Alexandra
    Giestas, Silvia
    Mendes, Sofia
    Agostinho, Claudia
    Campos, Mario J.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2012, 18 (04): : 277 - 281
12345